Table 1 Previously anti-retroviral naïve cases of HIV-GBS treated with HAART
Background/Demographics | Initial Treatment | Subsequent Progress | |||||
|---|---|---|---|---|---|---|---|
Reference | Age/Sex | GBS subtype | CD4 (cells/mm3) | IVIg given# | Mechanical Ventilation | First line HAART | |
Bani-Sadr et al 2002 [9] | 35/M | AIDP | 149 | Not stated | No | ZDV/3TC/IDV/RTV | Complete recovery, HAART continued |
Gisslén et al 2005[6] | 35/M | AIDP | 914 | No | No | d4T/3TC/SQV/NLF | Improvement at 3/12 & HAART stopped. GBS recurred 2/12 later. IVIg & 5/12 more HAART (same regimen). No further recurrence when HAART discontinued |
De Castro et al 2006 [10] | 38/M | AIDP | 502 | Yes | Yes | ZDV/3TC/IDV | Complete recovery on long-term HAART. 2 transient GBS recurrences during HAART interruption for unrelated toxicity; 1. Renal lithiasis at 18/12; IDV→RTV 2.GI upset at 31/12; wkly IVIg for 6/12 RTV→EFV |
Wagner et al 2007 [11] | 46/M | AMAN | 150 | No | No | Regimen not stated | Complete recovery, HAART continued |
Hiraga et al 2007 [4] | 56/M | Fisher/GBS overlap+ | 24 | Yes | No | Regimen not stated | Complete recovery, HAART continued |
Sloan et al 2008 [this paper] | 30/M | AIDP | 408 | Yes | No | ZVD/3TC/EFV | Complete recovery, HAART stopped at 6/12 |